Psychiatry medication safety
Bupropion XL: a past eating disorder still matters
A request for an activating antidepressant does not remove the need to recover seizure-risk history. The bupropion XL contraindications include information a patient may not consider current, including a prior eating disorder and a planned abrupt withdrawal from certain substances.
Sources checked October 9, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Read "current or prior" literally
The label contraindicates bupropion XL for patients with a current or prior diagnosis of bulimia or anorexia nervosa. A patient who says the disorder is in the past has provided relevant information, not removed the contraindication. Do not replace the label criterion with current weight, appearance or a general statement that the patient is doing well.
Ask sensitively for the actual history rather than inferring a diagnosis from body size. The issue is whether the named diagnosis is present now or occurred previously. This lesson does not imply that every eating pattern or low appetite is an eating-disorder diagnosis. It teaches a specific contraindication that can be missed when a history is summarized too briefly.
Recover planned withdrawal as well as ongoing use
The label contraindicates treatment during abrupt discontinuation of alcohol, benzodiazepines, barbiturates and antiepileptic drugs. A planned sudden stop can therefore matter even when the patient reports that they intend to be substance-free. A future withdrawal plan belongs in the medication assessment.
Do not solve that finding by instructing the patient to continue a substance indefinitely or by inventing a taper. The withdrawal plan needs the relevant clinical team. Likewise, a history of seizure disorder is a contraindication, not merely a reason to prefer a different XL tablet strength without prescriber review.
Do not stack formulations or create a catch-up dose
Bupropion is available in different release forms and for different prescribing purposes. Confirm all actual bupropion-containing products, strengths and schedules before adding an XL product. The same active ingredient can be duplicated even when two boxes have different names or stated purposes.
Seizure risk is dose-related, and the label advises gradual dose increases. XL tablets should be swallowed whole rather than crushed, divided or chewed. A forgotten dose is not a reason to take extra tablets; the medication guide warns that excessive dosing increases seizure risk. Formulation checks and total exposure remain relevant after history screening.
Keep interactions and symptom response in the review
The label identifies bupropion and its metabolites as CYP2D6 inhibitors, which can increase exposure to certain substrates. Review the actual medicine list, not just other antidepressants. A seemingly unrelated drug can be part of the interaction problem. Use product-specific guidance rather than assuming all substrates need the same adjustment.
If a seizure occurs during treatment, the label directs discontinuation and not restarting bupropion. This is not a routine adherence problem to fix with a lower self-selected dose. For an exam case, identify the contraindication or safety finding before comparing antidepressant benefits. This lesson does not choose treatment for an individual.
A worked case
A patient prescribed bupropion XL has no recent seizures, reports bulimia in college and plans to stop long-term clonazepam abruptly this weekend. They also have an old bupropion smoking-cessation prescription. Which details prevent a simple "start the new tablet tomorrow" answer?
- A prior bulimia diagnosis meets the label's current-or-prior criterion.
- Abrupt benzodiazepine discontinuation is another contraindicated setting.
- Recover whether the old bupropion product is actually being taken to avoid duplicate active-ingredient exposure.
Answer: The history and withdrawal plan require prescriber review before treatment. Current absence of seizures does not erase these findings.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. Does resolved bulimia become irrelevant under this XL label?
No. The contraindication explicitly includes prior diagnosis.
2. Is a planned abrupt clonazepam stop irrelevant because it has not happened yet?
No. It changes the safety assessment for the intended treatment period.
3. Can different bupropion brand purposes exclude duplication?
No. Verify active ingredient and actual use across products.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.